Adam, AhmedManda, S.O.M. (Samuel)2013-05-302013-05-302013-06Adam, A & Manda, SO 2013, 'How well does the PCA3–incorporated chun nomogram perform in predicting prostate biopsy outcome among South African men?', European Urology, vol. 63, no. 6, pp. e67-e86.0302-2838 (print)1421-993x (online)10.1016/j.eururo.2013.02.027http://hdl.handle.net/2263/21574The incidence of prostate cancer among South African men is just as significant as it is worldwide [1,2]. Although the role of the prostate cancer antigen 3 (PCA3) assay in predicting biopsy outcome has proven beneficial in a South African context [3], the assessment of its role incorporated into a prostate cancer risk calculator has not yet been explored on the continent of Africa. We aimed to assess the performance of the PCA3-incorporated Chun nomogram [4] and to compare its performance with other contemporary risk calculators.en© 2013 European Association of Urology. Published by Elsevier B.V. All rights reserved.Prostate cancerSouth African menPCA3–incorporated Chun NomogramPostprint Article